Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...

(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

Credit: Below the Sky / Shutterstock.com Two of Sanofi’s lunsekimig Phase II trials have met their primary endpoints in respiratory disease, while a study in atopic dermatitis failed to show benefit.

Rademikibart achieved rapid, durable efficacy results across all key endpoints through 52 weeks, with near- maximal responses achieved in ~90% of patients - - Rademikibart was well tolerated with safe ...

Phase 3 studies report meaningful reductions in exacerbations across broad patient groups Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved ...

Prostate cancer is one of the most common cancers diagnosed in men. Although it is the second-leading cause of cancer-related deaths for men in the U.S., it is also highly treatable, especially when ...

If you have obstructive sleep apnea (OSA), you might be offered a choice between instant breathing support and a long-term approach to target the condition’s root causes. Continuous positive airway ...

(RTTNews) - GSK plc (GSK) on Friday said the European Commission has approved Nucala as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD). The ...

Cold, dry weather can cause lip irritation, cracking, and cold sores. Blistex offers several over-the-counter products to treat cold sores and moisturize lips. Using antiviral creams at the first sign ...